Signature Tangles News Today : Breaking News, Live Updates & Top Stories | Vimarsana

tonight, for the first time in almost 20 years, there s a new drug just approved to treat people in the early phases of alzheimer s disease. reporter: in june, the food and drug administration green lit the first new drug approved to treat alzheimer s disease since 2003. now, according to the fda, the drug can reduce alzheimer s signature tangles and plaques of attorney proteins that block the neural pathways. but the approval was controversial, which many researchers, including the fda s own advisory committee, saying the evidence wasn t there to show it slows down cognitive decline. there s a growing concern about a surge of covid-19 cases in tokyo. instead of a metal count, we re tracking the covid count. it had been postponed the previous year, but this sumer, ....

Food And Drug Administration , Alzheimers Disease , Attorney Proteins , Signature Tangles , Neural Pathways , Wasn T , Advisory Committee , Original Coronavirus , Metal Count ,